Rush University Medical Center is among the backers of Transcarent’s series C round, which pushed the company’s overall financing to $298m.
Transcarent, a US-based operator of a personalised healthcare platform for employers, secured $200m in a series C round on Tuesday from a consortium featuring Rush University Medical Center, the teaching hospital of Rush University. Kinnevik and Human Capital co-led the round, with participation from health systems Northwell Health and Intermountain Healthcare, pharmaceutical firm Merck &…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
